Pharmacogenomics is the study of genetic variations that influence an individual’s response to drugs. The ideal medications and doses a person should be taking can be determined through genetic testing instead of trial and error.
Hereditary Cancer (CGx)
Our next-generation sequencing test for hereditary cancer analyzes 45 genes associated with increased risk to develop cancer. We use deletion and duplication sequencing in our CGx methodology, which allows us to determine not only small insertions and deletions, but also larger structural changes, changes that are often pathogenic, and changes which other sequencing providers cannot detect.
Alzheimer’s, Parkinson's, & Dementia (ADP)
This panel examines your risk for developing neurodegenerative disease, including Alzheimer’s, dementia, and Parkinson’s. This test includes the genes linked with development of early-onset Alzheimer's.
Diabetes and Obesity (DOW)
Next-generation sequencing of an individual's DNA can determine the patient’s root cause of diabetes and obesity. This test may also help tailor treatments to the patient’s genetic makeup.